Intellia Therapeutics Inc buy Chardan Capital
Start price
09.05.25
/
50%
€7.60
Target price
09.05.26
€60.64
Performance (%)
0.71%
Price
20:02
€7.65
Summary
This prediction is currently active. Since the start of the prediction for Intellia Therapeutics Inc the price has only changed by 0.71%. This prediction currently runs until 09.05.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -3.048% | -3.048% |
| iShares Core DAX® | 0.060% | 1.215% |
| iShares Nasdaq 100 | -3.065% | -0.519% |
| iShares Nikkei 225® | -2.094% | -3.066% |
| iShares S&P 500 | -1.657% | -0.069% |
Comments by Chardan_Capital for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $68.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€12.31
27.10.25
27.10.25
€41.25
27.10.26
27.10.26
-37.82%
20:02
20:02
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.69
28.02.25
28.02.25
€65.29
28.02.26
28.02.26
-21.01%
20:02
20:02
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.46
18.11.24
18.11.24
€86.10
18.11.25
18.11.25
-46.48%
19.11.25
19.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.98
07.08.23
07.08.23
€97.28
07.08.24
07.08.24
-45.29%
08.08.24
08.08.24